Seattle, WA, United States of America

William H Pitlick

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of William H. Pitlick

Introduction

William H. Pitlick is a notable inventor based in Seattle, WA, who has made significant contributions to the field of ocular treatments. With a total of six patents to his name, he has focused on developing methods and compositions that address various ocular disorders, including mydriasis and presbyopia.

Latest Patents

Among his latest patents, William has developed innovative methods and compositions for the treatment of mydriasis. These inventions provide methods, compositions, and kits containing an alpha-adrenergic antagonist, such as phentolamine. They are designed for use in monotherapy or as part of a combination therapy to treat patients suffering from presbyopia, mydriasis, and other ocular disorders.

Career Highlights

Throughout his career, William has worked with several prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Ocuphire Pharma, Inc. and Opus Genetics, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of effective treatments for ocular conditions.

Collaborations

William has collaborated with several professionals in his field, including Mina Sooch and Konstantinos Charizanis. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

William H. Pitlick's contributions to ocular treatment innovations highlight his dedication to improving patient care. His patents and collaborations reflect a commitment to advancing medical science and enhancing the quality of life for individuals with ocular disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…